Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection

被引:63
作者
Van de Velde, H [1 ]
Nagy, ZP [1 ]
Joris, H [1 ]
De Vos, A [1 ]
Van Steirteghem, AC [1 ]
机构
[1] Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
cumulus cells; hyaluronidase; ICSI; oocyte; pipette;
D O I
10.1093/humrep/12.10.2246
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of this study was Po compare concentrations of hyaluronidase and mechanical methods used to denude human oocytes from surrounding cumulus and corona cells prior to intracytoplasmic sperm injection (ICSI). Cumulus and corona cells were removed in two pipetting steps: first in a medium containing hyaluronidase, and then in a medium without enzyme, The first step in the procedure was investigated, Different hyaluronidase concentrations (rs, 39 or 10 IU/ml) and pipettes of different size (inner diameter 250 or >1000 mu m) were used to remove the cumulus cells, The time required to denude the oocytes was recorded. Metaphase II oocytes were injected, and the survival, fertilization, embryo development and pregnancy rates were evaluated. We found that by using a pipette with an inner diameter of at least 1000 mu m we mere able to decrease significantly the time an oocyte is exposed to hyaluronidase, even if the concentration of enzyme is very low (10 IU/ml). For the different conditions there was no statistically significant effect on the outcome in terms of survival, normal fertilization [two pronuclear (2PN)], parthenogenetic activation (1PN), abnormal fertilization (3PN), embryo development and pregnancy rates after ICSI. In conclusion, a concentration as low as 10 IU/ml hyaluronidase in combination with a pipette of at least 1000 FM inner diameter can be used successfully to denude oocytes fur microinjection.
引用
收藏
页码:2246 / 2250
页数:5
相关论文
共 33 条
[1]   Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection [J].
Abdelmassih, R ;
Sollia, S ;
Moretto, M ;
Acosta, AA .
FERTILITY AND STERILITY, 1996, 65 (03) :573-577
[2]   RESISTANCE OF HUMAN FOLLICULAR OOCYTES TO PARTHENOGENETIC ACTIVATION - DNA DISTRIBUTION AND CONTENT IN OOCYTES MAINTAINED INVITRO [J].
ABRAMCZUK, JW ;
LOPATA, A .
HUMAN REPRODUCTION, 1990, 5 (05) :578-581
[3]  
[Anonymous], 1983, EARLY MAMMALIAN DEV
[4]   CHARACTERIZATION OF ABNORMAL ONE PRONUCLEAR HUMAN OOCYTES BY MORPHOLOGY, CYTOGENETICS AND INSITU HYBRIDIZATION [J].
BALAKIER, H ;
SQUIRE, J ;
CASPER, RF .
HUMAN REPRODUCTION, 1993, 8 (03) :402-408
[5]  
Devroey P, 1996, HUM REPROD, V11, P1324
[6]  
FISHEL S, 1992, FERTIL STERIL, V57, P840
[7]  
FLAHERTY SP, 1995, HUM REPROD, V10, P2629
[8]   RECENT DEVELOPMENTS IN ASSISTED FERTILIZATION [J].
GORDTS, S ;
VERCRUYSSEN, M ;
ROZIERS, P ;
BASSIL, S ;
DEMYLLE, D ;
DONNEZ, J ;
CAMPO, R .
HUMAN REPRODUCTION, 1995, 10 :107-114
[9]   MICROMANIPULATION OF GAMETES FOR INVITRO ASSISTED FERTILIZATION [J].
IRITANI, A .
MOLECULAR REPRODUCTION AND DEVELOPMENT, 1991, 28 (02) :199-207
[10]  
JORIS H, 1997, IN PRESS HUM REPR S3, V12